Switch to:

Horizon Pharma PLC (HZNP) Ownership Data

Short Interest History (%)

This is the historical short interest of Horizon Pharma PLC, as measured by the Short Percentage Of Float.

Date Short Interest
May 15, 201510.57
April 30, 20157.55
April 15, 20156.75
March 31, 20158.02
March 13, 201510.03
February 27, 201510.34
February 13, 201510.39
January 30, 201518.83
January 15, 201521.6
December 31, 201421.93
December 15, 201424.56
November 28, 201425.51
November 14, 201425.67
October 31, 201427.62
October 15, 201431.19
September 30, 201429.75
September 15, 201422.41
August 29, 201422.18
August 15, 201422.05
July 31, 201421.19
July 15, 201421.99
June 30, 201422.56
June 13, 201423.11
May 30, 201421.59
May 15, 201421.26
April 30, 201422.44
April 15, 201426.79
March 31, 201428.83
March 14, 201427.12
February 28, 201433.51
February 14, 201432.34
January 31, 201428.01
January 15, 201426.62
December 31, 201322.04
December 13, 201320.98
November 29, 201321.21
November 15, 201312.37
October 31, 201312.3
October 15, 201312.22
September 30, 201311.88
September 13, 201312.68
August 30, 201312.2
August 15, 201311.55
July 31, 201310.82
July 15, 201311.38
June 28, 201310.65
June 14, 201310.31
May 31, 20139.88
May 15, 201310.35
April 30, 201310.35
April 15, 201310.71
March 28, 201310.7
March 15, 201310.86
February 28, 201333.65
February 15, 201334.7
January 31, 201335.6
January 15, 201336.23
December 31, 201235.18
December 14, 201235.59
November 30, 201229.28
November 15, 201226.81
October 31, 201222.81
October 15, 201221.49
September 28, 201233.22
September 14, 201234.86
August 31, 201240.02
August 15, 201243.39
July 31, 201236.13
July 13, 201228.11
June 29, 201220.41
June 15, 201212.68
May 31, 201212.22
May 15, 201212.64
April 30, 201211.52
April 13, 20129.75
March 30, 20127.17
March 15, 20126.12
February 29, 20124.78
February 15, 20123.87
January 31, 20123.22
January 13, 20122.53
December 30, 20112.18
December 15, 20111.73
November 30, 20111.05
November 15, 20110.99
October 31, 20111.02
October 14, 20111.03
September 30, 20110.08
September 15, 20110.09
August 31, 20110.09
August 15, 20110.01

Institutional Ownership History (%)

This the Institutional Ownership History of Horizon Pharma PLCPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
December 31, 201493
November 30, 201492
June 30, 201496
May 31, 201499
April 30, 2014100
March 31, 201481
February 28, 201477
January 31, 201479
December 31, 201380
November 30, 201376
October 31, 201374
September 30, 201368
August 31, 201371
July 31, 201372
June 30, 201371
May 31, 201370
April 30, 201351
March 31, 201369
February 28, 201370
January 31, 201371
December 31, 201273
November 30, 201274
October 31, 201274
September 30, 201269
August 31, 201272
July 31, 201272
June 30, 201261
May 31, 201261
April 30, 201261
March 31, 201252
February 29, 201288
January 31, 201261
December 31, 201138
November 30, 201138
October 31, 201138
September 30, 201129
August 31, 201127

Insider ownership (%)

This is the historical insider ownership of Horizon Pharma PLC. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
April 30, 20151
March 31, 20151
February 28, 20151
January 31, 20151
October 31, 20141
September 30, 20141
August 31, 20141
July 31, 20141
June 30, 20141
May 31, 20141
March 31, 20142
February 28, 20142
January 31, 20142
December 31, 20132
November 30, 20132
October 31, 20131
September 30, 20131
August 31, 20131
July 31, 20131
June 30, 20131
May 31, 20131
April 30, 20131
March 31, 20131
January 31, 20131
November 30, 20121
October 31, 20121
September 30, 20121
August 31, 20121
July 31, 20121

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr Virinder NohriaDirector214,8360.14%2014-11-13
Mr. Timothy P. WalbertChairman, President and CEO175,1250.11%2015-05-01
Mr. Robert J. De VaereEVP & CFO154,5140.1%2014-09-30
Mr. David George KellyEVP & Corporate Secretary125,888less than 0.1%2014-11-06
Jeffrey W. Sherman,M.D.EVP and Chief Medical Officer102,596less than 0.1%2014-01-02
Mr. Todd N. SmithEVP & Chief Commercial Officer54,711less than 0.1%2014-01-02
Robert CareyN/A23,245less than 0.1%2015-03-05
Mr. Michael AdattoSVP, Managed Care & Comm. Dev.22,911less than 0.1%2012-12-31
Mr. Brian K. BeelerN/A15,243less than 0.1%2015-05-06
Mr. Barry MozeN/A10,761less than 0.1%2015-05-19

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Vidara Therapeutics Holdings LLC31,350,0002014-09-2241.930.00322,905,000
Fidelity Management and Research Company   Premium Plus17,590,3802015-04-3013.200.00494,641,486
Deerfield Management Co   Premium Plus12,792,6892015-03-319.6010.76332,226,000
Fidelity® Select Biotechnology Portfolio7,292,5262015-03-315.471.36189,386,900
Broadfin Capital, LLC   Premium Plus7,053,5042015-03-315.2914.26183,179,000
Essex Woodlands Health Ventures, Inc5,815,9402014-04-308.140.0082,470,029
Vanguard Group, Inc.   Premium Plus5,506,9262015-03-314.130.01143,015,000
Essex Woodlands Health Ventures5,064,7312014-03-187.480.0061,891,013
Healthcor Management, L.p.   Premium Plus4,000,0002015-03-313.004.96103,880,000
BlackRock Fund Advisors3,722,5572015-05-212.620.22113,724,115

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK